O
OrbiMed Portfolio holdings
AUM
$4.59B
1-Year Est. Return
131.45%
This Fund
S&P 500
1 Year Est. Return
+131.45%
AUM
$4.59B
AUM Growth
-$301M
(-6.2%)
Holding
130
Top Buys
| 1 | +$109M | |
| 2 | +$76.6M | |
| 3 | +$43.7M | |
| 4 |
Mineralys Therapeutics
MLYS
|
+$31.5M |
| 5 |
uniQure
QURE
|
+$28.3M |
Top Sells
| 1 | +$87M | |
| 2 | +$65.3M | |
| 3 | +$61M | |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$57.8M |
| 5 |
Cigna
CI
|
+$56.4M |
Sector Composition
| 1 | Healthcare | 99.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RNAM
126
DELISTED
Avidity Biosciences
RNAM
| – | – |
-619,530
|
|
||
127
Roivant Sciences
ROIV
$21.6B
| – | – |
-2,190,907
|
|
||
|
RPTX
128
DELISTED
Repare Therapeutics
RPTX
| – | – |
-3,322,488
|
|